𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1227 LOW PREVALENCE OF DANOPREVIR RESISTANCE IDENTIFIED IN GT1B HCV PATIENTS WITH PRIOR NULL RESPONSE TREATED WITH DANOPREVIR PLUS LOW-DOSE RITONAVIR PLUS PEGIFNα-2A(40KD)/RBV FOR 12 WEEKS

✍ Scribed by Le Pogam, S.; Yan, J.M.; Chhabra, M.; Ilnicka, M.; Ji, Y.; Zhang, Y.; Shulman, N.; Klumpp, K.; Nájera, I.


Book ID
122548079
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
41 KB
Volume
54
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.